MEI Pharma, Inc. - רווח נקי למניה אחת בשנים עשר החודשים האחרונים LITS

Lite Strategy Inc (LITS) is an investment holding company that acquires biotech assets, mitigating risks through capital management. Its biopharmaceutical sector specializes in oncology, generating royalty income through collaborations. This price chart on GURU.Markets shows an EPS of -5.10. The company is currently undergoing restructuring without profitable assets, relying solely on legacy cash reserves in the absence of new inflows.

The metric is calculated as the percentage change in the rolling twelve-month earnings per share, allowing for the real-time tracking of capital generation efficiency without reporting gaps. This EPS YoY TTM trend distinguishes the fundamental stability of Lite Strategy Inc (LITS) from market speculation, reflecting the impact of biopharmaceutical asset digitalization and the implementation of ESG standards on the business's actual profitability.